Skip to main content
. 2024 Jan 24;24(3):224–234. doi: 10.2174/0118715206284107231120063630

Table 2.

Viability rates measured by the xCELLigence RTCA method after 24 hours of treatment of MCF-7 cells with different PTX concentrations.

PTX Concentration (µM) Viability (%)
Control (0 µM) 100
5 µM 46.64 ± 0.42**
10 µM 61.62 ± 0.49**
15 µM 37.25 ± 0.48**
20 µM 38.33 ± 0.13**
25 µM 31.78 ± 1.82**
50 µM 41.02 ± 0.12**
80 µM 37.65 ± 0.17**

Note: **p < 0.01 when compared with the control.